Quantcast

Latest stroke Stories

2014-04-02 08:32:43

MUNICH, Germany, April 2, 2014 /PRNewswire/ -- For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared with the general population[2] Daiichi Sankyo today announced its commitment to extend the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). The extension of the registry will include a specific...

2014-04-01 23:31:07

The DrugRisk Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) April 01, 2014 The prescription drug safety advocates at DrugRisk.com have added updated information to the site for patients who have used testosterone replacement therapy, or “low-T” drugs. A number of cases alleging the drugs caused heart attacks or stroke have been consolidated to a central federal court*....

2014-04-01 23:01:39

Susquehanna Health (SH) Cardiologist Dr. Liran Blum said new guidelines established by the American College of Cardiology (ACC) and American Heart Association (AHA) regarding the recommended use of cholesterol-reducing drugs called statins are appropriate and should be viewed primarily as guidelines when determining a patient’s course of treatment for the prevention of cardiovascular events such as heart attacks or strokes. “I think the guidelines and the recent [Duke University] study...

2014-04-01 12:59:16

Study Highlight: -Having blood pressure, blood sugar and cholesterol levels slightly higher than the recommended guidelines in early adulthood is associated with lower cognitive function in mid-life. Being heart healthy as a young adult  may increase your chance of staying mentally sharp in mid-life, according to new research in the American Heart Association journal Circulation. In a 25-year study on 3,381 people, 18- to 30-years-old, those with blood pressure, blood sugar and...

2014-03-31 13:24:14

Newly identified markers of inflammation have potential to contribute to better understanding of heart disease Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease. These newly identified markers of inflammation, GlycA and GlycB, have the potential to contribute to better understanding of the...

2014-03-31 12:07:41

In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American...

2014-03-31 08:29:45

RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO(®) (rivaroxaban), the most studied and broadly indicated oral Factor Xa inhibitor in the world today. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient...

2014-03-31 08:28:47

First patient enrolled in largest planned phase 3 study evaluating a novel oral anticoagulant in non-valvular atrial fibrillation patients undergoing electrical cardioversion PARSIPPANY, N.J., March 31, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor...

2014-03-31 00:21:42

LOS ANGELES, March 30, 2014 /PRNewswire/ -- The Torkzadeh Law Firm (TorkLaw) is currently investigating and accepting cases involving testosterone replacement therapy and any resulting cardiac event such as a heart attack, stroke, blood clots and even death. Testosterone lawsuits are being filed on behalf of victims and their families across the county. In January 2014, the Food and Drug Administration announced that it was investigating the safety of testosterone replacement drugs...

2014-03-29 23:01:20

The symptoms of a transient ischemic attack (TIA) often go away on their own, but they are a warning that a person is at greatly increased risk for a true stroke. Boston, MA (PRWEB) March 29, 2014 The term mini-stroke is often used to describe transient ischemic attack (TIA), a type of stroke. The "mini" has led to a lot of confusion about the true severity of this condition, according to the March 2014 Harvard Women's Health Watch. "Because of what the term implies,...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related